Universal Precautions: A Foundation of Infection Control in Healthcare
Universal precautions are a cornerstone of infection control practices in medicine. They involve treating all human blood and certain body fluids as potentially infectious for HIV, hepatitis B (HBV), and other blood-borne pathogens. This approach mandates avoiding contact with patients' bodily fluids through the consistent use of nonporous articles, such as medical gloves, goggles, and face shields. Introduced by the US Centers for Disease Control and Prevention (CDC) in 1985, following the AIDS outbreak in the 1980s, universal precautions aimed to standardize practices to minimize the risk of transmitting bloodborne pathogens in healthcare settings.
Historical Context and Evolution
The introduction of universal precautions in 1985-88 marked a significant step in addressing the growing concerns about bloodborne pathogen transmission. Prior to this, healthcare practices varied, leading to inconsistent protection for healthcare workers.
In 1987, a separate set of infection control guidelines known as body substance isolation was introduced by the CDC. This approach emphasized the avoidance of direct contact with all moist and potentially infectious body substances, regardless of whether visible blood was present. A major limitation of this approach was the recommendation to perform hand hygiene after glove removal only when hands were visibly soiled.
Over time, the understanding of infection control evolved, leading to the integration of universal precautions and body substance isolation into a more comprehensive approach. In 1996, the Guideline for Isolation Precautions in Hospitals was issued by the CDC through the Healthcare Infection Control Practices Advisory Committee (HICPAC), integrating the core elements of universal precautions and body substance isolation into what became known as standard precautions.
The Shift to Standard Precautions
Standard precautions represent the current best practice in infection control. They apply to all patients, regardless of their known or suspected infection status. These precautions are recommended whenever potential exposure occurs to:
Read also: Comprehensive Guide to Subsidized Student Loans
- Blood
- All body fluids, secretions, and excretions (excluding sweat), regardless of whether they contain visible blood
- Non-intact skin
- Mucous membranes
The core elements of standard precautions include:
- Hand Hygiene: Recognized as the most effective method for preventing the transmission of diseases.
- Personal Protective Equipment (PPE): Providing a physical barrier to prevent contamination of the skin, mucous membranes, respiratory tract, and clothing.
Core Elements of Standard Precautions
Hand Hygiene
Hand hygiene is paramount in preventing the spread of infection. The CDC recommends the following guidelines:
- Handwashing with Soap and Water: Required for 40 to 60 seconds when hands are visibly soiled, after using the restroom, or when exposure to spore-forming organisms, such as Clostridioides difficile, is suspected.
- Alcohol-Based Hand Rubs: May be used in the absence of visible soiling or concerns related to spores. The solution should be applied generously to ensure full hand coverage and rubbed until completely dry.
Hand hygiene is indicated in various situations:
- Before and after any direct patient contact, and between contacts with different patients, regardless of glove use
- Immediately after glove removal
- Before handling an invasive device
- After contact with blood, body fluids, secretions, excretions, non-intact skin, or contaminated items, even when gloves are worn
- While moving from a contaminated to a clean body site during patient care
- After contact with inanimate objects in the immediate vicinity of the patient
Routine and correct hand hygiene strengthens infection control efforts across the interprofessional team.
Personal Protective Equipment (PPE)
PPE acts as a crucial barrier between healthcare workers and potential sources of infection. The appropriate PPE should be selected based on the anticipated exposure.
Read also: The Science of Associative Learning
- Gloves: Gloves must be worn when contact with blood, body fluids, secretions, excretions, mucous membranes, or nonintact skin is anticipated. Gloves should be changed after contact with potentially infectious material, even within the same patient encounter, to prevent cross-contamination. Gloves should be removed before touching environmental surfaces or handling cleaning equipment.
- Facial Protection: A mask and eye protection or a face shield should be worn during procedures that may result in sprays or splashes of blood, body fluids, secretions, or excretions.
- Gowns: Should be worn to protect skin and clothing during procedures or activities where contact with blood or body fluids is anticipated.
Safe Injection Practices and Sharps Handling
Safe injection practices are essential to prevent the transmission of bloodborne pathogens. Key recommendations include:
- Using a new sterile syringe and needle for each injection
- Avoiding the reuse of needles or syringes
- Using single-dose vials whenever possible
- Designated containers for used needles and other sharps: Used needles should not be broken, bent, or manually manipulated. Recapping is discouraged, but a one-handed scoop technique should be used if this measure is necessary.
Transmission-Based Precautions
In addition to standard precautions, transmission-based precautions provide extra protection for patients known or suspected to be infected with specific pathogens. These precautions are implemented based on the mode of transmission of the infectious agent.
Airborne Precautions
Airborne precautions are necessary for patients with infections caused by pathogens transmitted through airborne droplet nuclei (≤5 µm). These particles can remain suspended in the air for extended periods.
- Room Requirements: Patients should be placed in a negative-pressure isolation room with 6 to 12 air changes per hour. The room door must remain closed at all times.
- Respiratory Protection: Healthcare workers should wear a respirator capable of filtering at least 95% of airborne particles, such as N95 respirators or powered air-purifying respirators.
Examples of infections requiring airborne precautions include measles, varicella (chickenpox), and tuberculosis.
Droplet Precautions
Droplet precautions are implemented for patients with infections caused by pathogens transmitted through respiratory droplets, typically 5 µm or larger. Transmission occurs within a short distance (3 to 6 feet) from the source.
Read also: Insightful Learning Explained
- Room Requirements: Patients should be placed in private rooms whenever possible.
- Masks: A surgical mask should be worn when within 6 feet of the patient.
Examples of infections requiring droplet precautions include influenza, pertussis (whooping cough), and mumps.
Contact Precautions
Contact precautions are used for patients with infections transmitted through direct or indirect contact. Indirect contact involves transmission through contaminated surfaces or objects.
- Room Requirements: Patients should be placed in private rooms whenever possible.
- Gloves and Gowns: Gloves and gowns should be donned before entering the patient's room and removed before exiting. Hand hygiene must be performed immediately afterward.
- Equipment: Whenever possible, dedicated equipment should remain in the patient's room. If shared use is necessary, all equipment must be properly cleaned and disinfected before use on another patient.
Examples of infections requiring contact precautions include Clostridioides difficile infection, methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE).
Specific Infections and Conditions Requiring Transmission-Based Precautions
Airborne Precautions
- Aspergillosis: If associated with massive soft tissue infection requiring copious drainage and repeated irrigations
- COVID-19: Requires both airborne and droplet precautions
- Herpes zoster: For the duration of illness, if disseminated or in immunocompromised patients
- Measles: For 4 days after rash onset in immunocompetent hosts; for the duration of illness in immunocompromised individuals
- Monkeypox: Until the diagnosis is confirmed and smallpox has been excluded
- Severe acute respiratory syndrome: For the duration of illness plus 10 days after fever and respiratory symptoms have resolved or improved
- Smallpox: For the duration of illness
- Pulmonary or laryngeal tuberculosis: Until clinical improvement with effective therapy and 3 consecutive negative sputum smears
- Extrapulmonary tuberculosis with draining lesions: Until clinical improvement and cessation of drainage or 3 consecutive negative cultures
- Varicella zoster: Until all lesions have crusted and dried
Droplet Precautions
- Adenovirus pneumonia: For the duration of illness
- COVID-19: Requires both droplet and airborne precautions
- Pharyngeal diphtheria: Until completion of antibiotics and 2 negative cultures taken 24 hours apart
- Haemophilus influenzae type b causing epiglottitis or meningitis: Until 24 hours after initiating effective therapy
- Influenza during a pandemic: For the duration of illness
- Neisseria meningitidis causing meningitis, sepsis, or pneumonia: Until 24 hours after initiating effective therapy
- Mumps: For 5 days after symptom onset
- Mycoplasma pneumoniae: For the duration of illness
- Parvovirus B19 (acute or chronic disease in an immunocompromised host): For 7 days in acute infection; for the duration of hospitalization in chronic cases
- Pertussis: For 5 days after initiating therapy
- Yersinia pestis during a pneumonic plague: For 48 hours after effective treatment begins
- Group A Streptococcus causing pneumonia, pharyngitis, scarlet fever, or serious invasive disease: Until 24 hours after initiating effective therapy
- Rhinovirus: For the duration of illness
- Rubella: Until 7 days after rash onset
- Severe acute respiratory syndrome: For the duration of illness plus 10 days after resolution or improvement of fever and respiratory symptoms
- Ebola, Marburg, Crimean-Congo, and Lassa fever viruses (viral hemorrhagic fevers): For the duration of illness
Contact Precautions
- Extensive abscess with drainage: For the duration of illness until drainage ceases
- Adenovirus: For the duration of illness
- Burkholderia cepacia in patients with cystic fibrosis: For the duration of illness
- Bronchiolitis: For the duration of illness
- Clostridioides difficile infection: For the duration of illness
- Congenital rubella: Until 1 year of age, or until urine and nasopharyngeal cultures are consistently negative after 3 months of age
- Viral conjunctivitis: For the duration of illness
- Cutaneous diphtheria: Until completion of antibiotics and 2 negative cultures taken 24 hours apart
- Furunculosis caused by Staphylococcus aureus: For the duration of illness
- Rotavirus: For the duration of illness
- Hepatitis A in incontinent patients: For the duration of hospitalization in children younger than 3, 2 weeks after onset in those aged 3 to 14, and 1 week after onset in those older than 14
- Neonatal, disseminated, severe, or mucocutaneous herpes simplex: Until lesions crust and dry
- Disseminated herpes zoster: For the duration of illness
- Human metapneumovirus: For the duration of illness
- Impetigo: Until 24 hours after initiating effective therapy
- Head lice: Until 24 hours after initiating effective therapy
- Monkeypox: Until all lesions have crusted
- Multidrug-resistant organism infection or colonization: While ongoing transmission risk is evident, or open wounds cannot be covered
- Parainfluenza virus: For the duration of illness
- Poliomyelitis: For the duration of illness
- Large, infected pressure ulcers: For the duration of illness
- Respiratory syncytial virus: For the duration of illness in infants, young children, and immunocompromised adults
- Staphylococcal scalded skin syndrome (Ritter disease): For the duration of illness
- Scabies: Until 24 hours after initiating effective treatment
- Severe acute respiratory syndrome: For the duration of illness plus 10 days after resolution or improvement of fever and respiratory symptoms
- Smallpox: For the duration of illness
- Major S aureus skin infection: For the duration of illness
- Major Group A Streptococcus skin infection: Until 24 hours after initiating effective therapy
- Extrapulmonary tuberculosis with draining lesions: Until clinical improvement and cessation of drainage or 3 consecutive negative cultures
- Vaccinia: Until lesions crust and dry
- Varicella-zoster: Until all lesions have crusted and dried
- Viral hemorrhagic fevers, such as Ebola, Marburg, Crimean-Congo, and Lassa: For the duration of illness
- Major wound infections: For the duration of illness
Implementation and Training
Effective implementation of universal and standard precautions requires a multi-faceted approach, including:
- Administrative Support: Healthcare facilities must provide the necessary resources, policies, and procedures to support adherence to precautions.
- Staff Training: Regular training and education are crucial to ensure that healthcare workers understand the principles of infection control and can correctly implement precautions. Medical students should be instructed during pre-clinical years with didactic instruction, demonstrations and opportunities for practice. Universal precaution training should be conducted again in the clinical years for reinforcement and reduction of exposures to blood-borne pathogens during clinical training and subsequent clinical practice.
- Access to Protective Equipment: PPE must be readily available and accessible to all healthcare workers.
- Monitoring and Feedback: Regular monitoring of adherence to precautions and providing feedback to healthcare workers can help identify areas for improvement.
Challenges and Considerations
Despite the well-established guidelines, several challenges can hinder the consistent implementation of universal and standard precautions. These include:
- Lack of Adherence: Healthcare workers may not always adhere to precautions due to factors such as time constraints, discomfort, or perceived low risk.
- Resource Limitations: Inadequate resources, such as insufficient PPE or hand hygiene supplies, can impede implementation.
- Emerging Infectious Diseases: The emergence of new infectious diseases, such as COVID-19, requires adaptation of existing precautions and the implementation of new strategies.
- Complacency: When safety protocols are not being actively monitored and enforced, staff may develop bad habits and be lulled into a false sense of security.
OSHA Regulations and Compliance
The Occupational Safety and Health Administration (OSHA) plays a critical role in ensuring workplace safety in healthcare settings. OSHA's Bloodborne Pathogens Standard (29 CFR 1910.1030) mandates that employers establish and implement an Exposure Control Plan to eliminate or minimize employee exposure to bloodborne pathogens.
The Exposure Control Plan must include:
- Exposure determination
- Methods of compliance, including universal precautions, engineering and work practice controls, and PPE
- Hepatitis B vaccination
- Post-exposure evaluation and follow-up
- Communication of hazards to employees
- Recordkeeping
OSHA also requires that employers provide training to employees on bloodborne pathogens and the measures to prevent exposure.
Universal Precautions Beyond Healthcare
The principles of universal precautions extend beyond traditional healthcare settings. Any environment where exposure to blood or body fluids is possible, such as schools, correctional facilities, and emergency response services, should implement similar precautions to protect individuals from infection.
tags: #universal #precautions #definition
